tiprankstipranks
Travere Therapeutics (CH:17R)
:17R
Switzerland Market

Travere Therapeutics (17R) Earnings Dates, Call Summary & Reports

0 Followers

Earnings Data

Report Date
Oct 22, 2026
After Close (Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
0.02
Last Year’s EPS
0.23
Same Quarter Last Year
Based on 12 Analysts Ratings

Travere Therapeutics (CH:17R) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CH:17R Q2 2026 Earnings Report

CH:17R Upcoming Earnings
Travere Therapeutics's next earnings date is estimated for October 22, 2026, based on past reporting schedules.

CH:17R Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 22, 2026
2026 (Q3)
0.02 / -
0.227
2026 (Q2)
-0.11 / -0.30
-0.114-164.29% (-0.19)
2026 (Q1)
-0.20 / -0.32
-0.38214.89% (+0.06)
2025 (Q4)
<0.01 / 0.02
-0.593104.11% (+0.62)
2025 (Q3)
-0.25 / 0.23
-0.568140.00% (+0.80)
2025 (Q2)
-0.25 / -0.11
-0.73984.62% (+0.63)
2025 (Q1)
-0.46 / -0.38
-1.42973.30% (+1.05)
2024 (Q4)
-0.46 / -0.59
-0.95838.14% (+0.37)
2024 (Q3)
-0.54 / -0.57
1.599-135.53% (-2.17)
2024 (Q2)
-0.64 / -0.74
-0.91719.47% (+0.18)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

FAQ

When does Travere Therapeutics (CH:17R) report earnings?
Travere Therapeutics (CH:17R) is schdueled to report earning on Oct 22, 2026, After Close (Confirmed).
    What is Travere Therapeutics (CH:17R) earnings time?
    Travere Therapeutics (CH:17R) earnings time is at Oct 22, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Travere Therapeutics stock?
          The P/E ratio of Travere Therapeutics is N/A.
            What is CH:17R EPS forecast?
            CH:17R EPS forecast for the fiscal quarter 2026 (Q3) is 0.02.